Craig Tooman - Exec VP Finance, Enzon Pharmaceuticals Inc

As of April 5, 2006


Craig Tooman Net Worth

  • Net worth is estimated to be at least $4.68M
  • Owns at least 26,000 units of Enzon Pharmaceuticals Inc stock

Craig Tooman Compensation at Enzon Pharmaceuticals Inc in 2018

  • Earned a $360,000 salary
  • Rewarded $191,751 in stock value and options
  • Received a total compensation of $863,604

Craig Tooman Trading

  • Largest purchase of shares was 1,000 units , worth over $6.87K on March 7, 2006
  • In total has made about 4 transactions over a year
  • Usually trades in March, November, April and January, with the busiest year in 2006 and 2005
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Enzon Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 107,500 units sold on August 17, 2021 by Jonathan Couchman, Couchman Family Fund, Xstelos Corp and Myrexis Inc worth over $41.9K
  • In the last 17 years, insiders at Enzon Pharmaceuticals Inc sold an estimated value of $14.67M and bought an estimated value of $10.97M
  • The most active traders are Robert Lebuhn, Director,  Ivan Horak, EVP,  and Craig A Tooman, Exec VP Finance
  • Insider trading is most common in January, with the busiest year in 2010

ENZON PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1